These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
411 related items for PubMed ID: 6142433
1. [Clinical study of a new beta-adrenergic receptor blocking substance, indenolol]. Cirino D, Savonelli C, Maggi GC. Minerva Cardioangiol; 1983 Nov; 31(11):671-6. PubMed ID: 6142433 [No Abstract] [Full Text] [Related]
2. Clinical use of the beta1-selective adrenoceptor blocker metoprolol in hypertension, angina pectoris and arrhythmias. Ann Clin Res; 1981 Nov; 13 Suppl 30():1-72. PubMed ID: 6117243 [No Abstract] [Full Text] [Related]
3. [Studies of various beta receptor blockers in clinical anesthesia--6. Comparative study of YB-2 and other drugs]. Miyazaki M, Sakaguchi C. Masui; 1975 Jul; 24(7):669-75. PubMed ID: 240952 [No Abstract] [Full Text] [Related]
4. Effect of indenolol treatment on beta-adrenergic receptors of polymorphonucleates in essential hypertension. Corradi L, Groothold G, Venco A, Mailland F, Negri F, Grandi A, Barzizza F, Finardi G. J Hypertens Suppl; 1986 Dec; 4(6):S137-40. PubMed ID: 2886569 [Abstract] [Full Text] [Related]
5. Incidence of side effects during the application of placebo and active therapy (Tobanum) in patients suffering from hypertension, angina pectoris and arrhythmia. Török E, Kósa E, Szontagh M, Juvancz P, Eggenhofer J, Borvendég J. Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):650-6. PubMed ID: 2868999 [Abstract] [Full Text] [Related]
6. [1st experiences with the clinical use of a new beta-blocking agent (tolamolol) in some heart diseases]. Neviani V, Tosi P, Prampolini ML. Clin Ter; 1976 Jun 15; 77(5):451-8. PubMed ID: 12901 [No Abstract] [Full Text] [Related]
7. A report on the clinical efficacy of nadolol--a new long acting beta-blocker. Hill LS, Fand RS. Ir Med J; 1979 Dec 15; 72(12):522-9. PubMed ID: 44273 [No Abstract] [Full Text] [Related]
8. Comparative review of beta-blocking agents. Jackson EA, Sullman SA. Conn Med; 1984 Apr 15; 48(4):213-5. PubMed ID: 6143648 [No Abstract] [Full Text] [Related]
9. [Our experience on the clinical use of nadolol]. Trinchero R, Moratti M, Ghisio A, Pomari F, Artesani S, Barbano G. Minerva Cardioangiol; 1985 Oct 15; 33(10):629-34. PubMed ID: 2867492 [No Abstract] [Full Text] [Related]
10. Clinical examination of the beta-adrenergic receptor blocking activity of Tobanum in spontaneously occurring anginas. Sipos Z, Hollósi Z, Iskum M. Ther Hung; 1984 Oct 15; 32(2):74-8. PubMed ID: 6152819 [No Abstract] [Full Text] [Related]
12. [The beta-blocking agents. Their use in cardiology]. Ben Naceur M, Houissa D. Tunis Med; 1972 Oct 15; 50(5):381-5. PubMed ID: 4148309 [No Abstract] [Full Text] [Related]
13. [Therapy and differential therapy with beta sympathicolytic drugs]. Frisch P. Med Klin; 1975 Oct 17; 70(42):1682-7. PubMed ID: 241898 [No Abstract] [Full Text] [Related]
15. [The antihypertensive effect of a new beta-adrenergic blocking drug metroprolol in combination with chlorthalidone]. Jäättelä A, Pyöräiä K. Duodecim; 1976 Oct 17; 92(11):597-603. PubMed ID: 7445 [No Abstract] [Full Text] [Related]
16. [Clinical experiences with -receptor blockader Propranolol in the treatment of angina pectoris and tachycrdiac arrhythmias]. Eisenreich R. Z Arztl Fortbild (Jena); 1970 Jun 01; 64(11):529-34. PubMed ID: 4106268 [No Abstract] [Full Text] [Related]